HealthcareServices

Disease Registry Software Industry Insights: Market Forecast to 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Disease Registry Software Market Size Likely To Evolve From 2025 Through 2034?

The disease registry software market has experienced substantial expansion in recent years. It is anticipated to grow from $1.39 billion in 2024 to $1.55 billion in 2025, at a compound annual growth rate (CAGR) of 11.6%. The historical growth can be attributed to the escalating burden of chronic diseases, an increase in clinical research and trials, the rising prevalence of rare diseases, the rapid adoption of electronic health records (EHRs), and the growing prevalence of chronic diseases.

The disease registry software market is anticipated to experience substantial growth in the coming years, with its valuation expected to reach $2.38 billion by 2029, expanding at a compound annual growth rate (CAGR) of 11.2%. This projected expansion can be attributed to several factors, including the increasing adoption of value-based care approaches, the growing application of real-world evidence (RWE), the widening reach of precision medicine programs, the rise in chronic and lifestyle-related health conditions, and a heightened focus on patient-centric healthcare delivery. Key trends expected in this period encompass advancements in healthcare information technology (IT) infrastructure, the incorporation of telehealth and remote monitoring capabilities, integration with the internet of things (IoT) and wearable devices, sophisticated data visualization and dashboard functionalities, and the use of blockchain for improved data security and interoperability.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

Which Industry Drivers Are Expected To Accelerate The Disease Registry Software Market From 2025 To 2029?

Future expansion of the disease registry software market is anticipated, driven by the growing integration of personalized medicine. This medical methodology customizes treatment and prevention plans based on a person’s distinct genetic profile, lifestyle choices, and environmental factors. The rising implementation of personalized medicine largely stems from progress in genomics, allowing for accurate detection of genetic differences and bespoke therapies for patients. Disease registry software facilitates personalized medicine by systematically gathering and overseeing patient health information, which in turn permits customized treatment strategies and enhances clinical judgments. This software simplifies access to and analysis of data, thereby bettering patient results and fostering the development of precision healthcare. An example illustrating this trend is that, as reported in February 2024 by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023, a notable rise from the 12 approvals in 2022. Consequently, the expanding use of personalized medicine is fueling the expansion of the disease registry software market.

What Are The Major Segments Identified In The Disease Registry Software Market?

The disease registry software market covered in this report is segmented as

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

What Are The Major Trends Driving The Growth Of The Disease Registry Software Market?

Major companies in the disease registry software market are concentrating on developing patient-centric registries, such as digital records to observe outcomes and support customized care. Digital registers are electronic systems or software platforms that methodically collect, store, and manage patient health information, thereby replacing traditional paper-based registries. For instance, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, introduced the CONNECT-HCM Registry. This is a nationwide digital registry established to improve the understanding and management of hypertrophic cardiomyopathy (HCM), which is the most common genetic cardiovascular disease. The registry allows for direct patient enrollment beyond individual centers, thereby addressing long-standing gaps in diagnosis and care. This platform connects registry data with electronic health records via Arboretum’s Hugo Connect platform and aids researchers in tracking symptoms, imaging, treatments, and outcomes over time.

Which Major Industry Participants Are Leading The Disease Registry Software Market Growth?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., and Vanderbilt University.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

How Do Regional Market Performances Compare Within The Disease Registry Software Industry?

North America was the largest region in the disease registry software market in 2024. The regions covered in disease registry software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28208&type=smp

Browse Through More Reports Similar to the Global Disease Registry Software Market 2025, By The Business Research Company

Patient Registry Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report

Disease Management Apps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795